• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）-初治疗养院居民中 BNT162b2 信使 RNA 疫苗反应降低。

Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.

机构信息

Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Geriatric Research, Education and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.

出版信息

Clin Infect Dis. 2021 Dec 6;73(11):2112-2115. doi: 10.1093/cid/ciab447.

DOI:10.1093/cid/ciab447
PMID:33993265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8240817/
Abstract

After BNT162b2 messenger RNA vaccination, antibody levels to spike, receptor-binding domain, and virus neutralization were examined in 149 nursing home residents and 110 healthcare worker controls. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-naive nursing home residents' median post-second vaccine dose antibody neutralization titers are one-quarter that of SARS-CoV-2-naive healthcare workers.

摘要

在接受 BNT162b2 信使 RNA 疫苗接种后，对 149 名养老院居民和 110 名医护人员对照者的刺突、受体结合域和病毒中和抗体水平进行了检测。未感染过严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）的养老院居民第二次疫苗接种后抗体中和滴度中位数为未感染过 SARS-CoV-2 的医护人员的四分之一。

相似文献

1
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）-初治疗养院居民中 BNT162b2 信使 RNA 疫苗反应降低。
Clin Infect Dis. 2021 Dec 6;73(11):2112-2115. doi: 10.1093/cid/ciab447.
2
Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.养老院中初次接触严重急性呼吸综合征冠状病毒2的居民对BioNTech/辉瑞2019冠状病毒病疫苗的抗体反应较差。
Clin Infect Dis. 2022 Aug 24;75(1):e695-e704. doi: 10.1093/cid/ciab998.
3
Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.在养老院居民中，接种 SARS-CoV-2 BNT162b2 mRNA 加强针后抗体明显升高。
Influenza Other Respir Viruses. 2022 Nov;16(6):1066-1071. doi: 10.1111/irv.13030. Epub 2022 Aug 12.
4
Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents.先前的 SARS-CoV-2 感染、年龄和虚弱与养老院居民 6 个月疫苗诱导的抗刺突抗体滴度有关。
J Am Med Dir Assoc. 2022 Mar;23(3):434-439. doi: 10.1016/j.jamda.2021.12.001. Epub 2022 Jan 11.
5
T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.养老院居民中初次接种和加强接种 SARS-CoV-2 信使 RNA 疫苗后的 T 细胞介导的反应。
J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7.
6
Achievement of sufficient antibody response after a fourth dose of wild-type SARS-CoV-2 mRNA vaccine in nursing home residents.在养老院居民中，第四剂野生型 SARS-CoV-2 mRNA 疫苗后抗体反应的获得情况。
Immun Inflamm Dis. 2023 Aug;11(8):e962. doi: 10.1002/iid3.962.
7
Strong Decay of SARS-CoV-2 Spike Antibodies after 2 BNT162b2 Vaccine Doses and High Antibody Response to a Third Dose in Nursing Home Residents.两剂 BNT162b2 疫苗接种后对 SARS-CoV-2 刺突抗体的强烈衰减，以及在疗养院居民中对第三剂的高抗体反应。
J Am Med Dir Assoc. 2022 May;23(5):750-753. doi: 10.1016/j.jamda.2022.02.006. Epub 2022 Feb 23.
8
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应（UNCoVER）：一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
9
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?医护人员和养老院居民中 BNT162b2 mRNA 疫苗反应降低是否与缺乏疫苗副作用相关？
Aging Clin Exp Res. 2021 Nov;33(11):3151-3160. doi: 10.1007/s40520-021-01987-9. Epub 2021 Oct 15.
10
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.辉瑞-BioNTech 新冠疫苗接种 6 个月后针对 SARS-CoV-2 关注变异株的抗体反应
Microbiol Spectr. 2022 Apr 27;10(2):e0225221. doi: 10.1128/spectrum.02252-21. Epub 2022 Mar 9.

引用本文的文献

1
COVID-19 mRNA vaccine immune response to the addition of osteopathic manipulative treatment with lymphatic pumps: a randomized controlled trial.COVID-19信使核糖核酸疫苗联合淋巴泵整骨手法治疗的免疫反应：一项随机对照试验
Virus Res. 2025 Jul 14;359:199607. doi: 10.1016/j.virusres.2025.199607.
2
Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months.6个月后老年人对SARS-CoV-2感染的免疫反应降低。
Front Immunol. 2025 May 9;16:1596065. doi: 10.3389/fimmu.2025.1596065. eCollection 2025.
3
Dynamics of SARS-CoV-2 IgG in Nursing Home Residents in Belgium Throughout Three BNT162b2 Vaccination Rounds: 19-Month Follow-Up.

本文引用的文献

1
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.多种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体可逃避疫苗诱导的体液免疫的中和作用。
Cell. 2021 Apr 29;184(9):2523. doi: 10.1016/j.cell.2021.04.006.
2
COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021.2021 年 3 月，在接种疫苗计划后，肯塔基州一家熟练护理机构中与 SARS-CoV-2 R.1 谱系变异株相关的 COVID-19 疫情。
MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):639-643. doi: 10.15585/mmwr.mm7017e2.
3
Short-term impact of nursing home SARS-CoV-2 vaccinations on new infections, hospitalizations, and deaths.
比利时养老院居民在三轮BNT162b2疫苗接种期间的新冠病毒IgG动态：19个月随访
Vaccines (Basel). 2025 Apr 15;13(4):409. doi: 10.3390/vaccines13040409.
4
COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residents.新冠病毒病加强针可减少养老院居民抗体反应中的性别差异。
Aging Clin Exp Res. 2025 Mar 8;37(1):73. doi: 10.1007/s40520-025-02990-0.
5
Epidemiological and immunological characteristics of middle-aged and elderly people in housing estates after Omicron BA.5 wave in Jinan, China.中国济南奥密克戎BA.5毒株流行后小区中老年人群的流行病学和免疫学特征
Heliyon. 2024 Sep 25;10(19):e38382. doi: 10.1016/j.heliyon.2024.e38382. eCollection 2024 Oct 15.
6
Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination.比利时养老院居民和工作人员在初次接种BNT162b2疫苗后2个月、4个月和6个月时的SARS-CoV-2抗体水平随访
Vaccines (Basel). 2024 Aug 22;12(8):951. doi: 10.3390/vaccines12080951.
7
Kinetics of pro- and anti-inflammatory spike-specific cellular immune responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: a prospective longitudinal study in Japan.新型冠状病毒肺炎mRNA初次和加强疫苗接种后长期护理机构居民中促炎和抗炎刺突特异性细胞免疫反应的动力学：日本一项前瞻性纵向研究
Immun Ageing. 2024 Jun 22;21(1):41. doi: 10.1186/s12979-024-00444-1.
8
Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers.在养老院居民和医护人员中，BNT162b2 mRNA 疫苗初级和加强剂量后的体液免疫应答的亲和成熟度。
Geroscience. 2024 Dec;46(6):6183-6194. doi: 10.1007/s11357-024-01215-y. Epub 2024 May 25.
9
Longitudinal Analysis of Nursing Home Residents' T-Cell Responses After SARS-CoV-2 mRNA Vaccinations Shows Influence of Biological Sex and Infection History.养老院居民接种 SARS-CoV-2 mRNA 疫苗后 T 细胞反应的纵向分析显示了生物性别和感染史的影响。
J Infect Dis. 2024 Sep 23;230(3):635-644. doi: 10.1093/infdis/jiae234.
10
Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents-Georgia, October 2020-July 2022.养老院居民中感染 SARS-CoV-2 和接种 COVID-19 疫苗的免疫反应动力学 - 乔治亚州，2020 年 10 月至 2022 年 7 月。
PLoS One. 2024 Apr 16;19(4):e0301367. doi: 10.1371/journal.pone.0301367. eCollection 2024.
养老院 SARS-CoV-2 疫苗接种对新感染、住院和死亡的短期影响。
J Am Geriatr Soc. 2021 Aug;69(8):2063-2069. doi: 10.1111/jgs.17176. Epub 2021 Apr 16.
4
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.Ad26.COV2.S 新冠疫苗 1/2a 期临床试验的中期结果。
N Engl J Med. 2021 May 13;384(19):1824-1835. doi: 10.1056/NEJMoa2034201. Epub 2021 Jan 13.
5
COVID-19-neutralizing antibodies predict disease severity and survival.COVID-19 中和抗体可预测疾病严重程度和存活率。
Cell. 2021 Jan 21;184(2):476-488.e11. doi: 10.1016/j.cell.2020.12.015. Epub 2020 Dec 15.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
7
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
8
Influence of immune aging on vaccine responses.免疫衰老对疫苗反应的影响。
J Allergy Clin Immunol. 2020 May;145(5):1309-1321. doi: 10.1016/j.jaci.2020.03.017.
9
Immunosenescence and human vaccine immune responses.免疫衰老与人类疫苗免疫反应。
Immun Ageing. 2019 Sep 13;16:25. doi: 10.1186/s12979-019-0164-9. eCollection 2019.
10
Antibody response to influenza vaccination in the elderly: a quantitative review.老年人对流感疫苗接种的抗体反应：一项定量综述。
Vaccine. 2006 Feb 20;24(8):1159-69. doi: 10.1016/j.vaccine.2005.08.105. Epub 2005 Sep 19.